HTFLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Heartflow, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$51.02+2.73 (+5.65%)
Close on Oct 19, 2026
- Market cap
- $4.41B
- P/E (TTM)
- –
- Dividend yield
- –
Heartflow, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 80.1%
- Operating margin
- -37.8%
- Net margin
- -55.8%
- Return on equity, FY2025
- 41.8%
Financial strength
- Current ratio
- 5.08
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 77.9%
Valuation
- P/E ratio
- –
- Price to sales
- 20.79
- Price to book
- 15.76
- Dividend yield
- –